Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia

被引:6
作者
Alvarez-Larrán, A
Villamor, N
Hernández-Boluda, JC
Ferrer, A
Camós, M
Campo, E
López-Guillermo, A
机构
[1] Hosp Clin Barcelona, Dept Hematol, Inst Hematol & Oncol, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer, Hematopathol Unit, E-08036 Barcelona, Spain
来源
CLINICAL LYMPHOMA | 2001年 / 2卷 / 03期
关键词
natural killer cell; CHOP; cutaneous lesions; Epstein-Barr virus;
D O I
10.3816/CLM.2001.n.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Blastic natural killer (NK)-cell leukemia/lymphoma is a neoplasm of NK origin with aggressive behavior. The disease affects mainly elderly people and often presents with skin lesions and overt leukemia. Blastic morphology, an NK-cell immunophenotype, and lack of association with Epstein-Barr virus are the clues for the diagnosis. We report herein, the case of a patient with a blastic NK-cell leukemia/lymphoma with overt leukemia at diagnosis, who achieved a complete response after CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy. However, the patient relapsed a few months later and died due to disease progression. Cases of blastic NK-cell leukemia/lymphoma previously reported are briefly reviewed.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 18 条
[1]  
BRODY JP, 1995, CANCER, V75, P2474, DOI 10.1002/1097-0142(19950515)75:10<2474::AID-CNCR2820751013>3.0.CO
[2]  
2-Y
[3]   Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm [J].
Chan, JKC ;
Sin, VC ;
Wong, KF ;
Ng, CS ;
Tsang, WYW ;
Chan, CH ;
Cheung, MMC ;
Lau, WH .
BLOOD, 1997, 89 (12) :4501-4513
[4]   Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study [J].
DiGiuseppe, JA ;
Louie, DC ;
Williams, JE ;
Miller, DT ;
Griffin, CA ;
Mann, RB ;
Borowitz, MJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (10) :1223-1230
[5]   A primary cutaneous non-T, non-B CD4(+), CD56(+) lymphoma [J].
Dummer, R ;
Potoczna, N ;
Haffner, AC ;
Zimmermann, DR ;
Gilardi, S ;
Burg, G .
ARCHIVES OF DERMATOLOGY, 1996, 132 (05) :550-553
[6]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849
[7]  
HARRIS NL, 1994, BLOOD, V84, P1361
[8]   AGGRESSIVE NATURAL-KILLER-CELL LEUKEMIA LYMPHOMA - REPORT OF 4 CASES AND REVIEW OF THE LITERATURE - POSSIBLE EXISTENCE OF A NEW CLINICAL ENTITY ORIGINATING FROM THE 3RD LINEAGE OF LYMPHOID-CELLS [J].
IMAMURA, N ;
KUSUNOKI, Y ;
KAWAHA, K ;
YUMURA, K ;
HARA, J ;
ODA, K ;
ABE, K ;
DOHY, H ;
INADA, T ;
KAJIHARA, H ;
KURAMOTO, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (01) :49-59
[9]   Classification of natural killer (NK) cell and NK-like T-cell malignancies [J].
Jaffe, ES .
BLOOD, 1996, 87 (04) :1207-1210
[10]   Report of the workshop on nasal and related extranodal angiocentric T natural killer cell lymphomas - Definitions, differential diagnosis, and epidemiology [J].
Jaffe, ES ;
Chan, JKC ;
Su, IJ ;
Frizzera, G ;
Mori, S ;
Feller, AC ;
Ho, FCS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (01) :103-111